Exelixis
EXEL
#1660
Rank
C$14.39 B
Marketcap
$50.42
Share price
1.26%
Change (1 day)
73.89%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Exelixis (EXEL) - Total assets

Total assets on the balance sheet as of September 2024 : C$4.11 Billion

According to Exelixis's latest financial reports the company's total assets are C$4.11 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Exelixis - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-12-31C$3.90 B-6.36%
2022-12-31C$4.16 B25%
2021-12-31C$3.33 B22.35%
2020-12-31C$2.72 B10.66%
2019-12-31C$2.46 B27.12%
2018-12-31C$1.93 B135.16%
2017-12-31C$0.82 B2.91%
2016-12-31C$0.80 B73.65%
2015-12-31C$0.46 B22.89%
2014-12-31C$0.37 B-29.98%
2013-12-31C$0.53 B-25.29%
2012-12-31C$0.71 B79.25%
2011-12-31C$0.40 B10.92%
2010-12-31C$0.36 B-0.19%
2009-12-31C$0.36 B-26.01%
2008-12-31C$0.48 B18.78%
2007-12-31C$0.41 B-10.7%
2006-12-31C$0.46 B18.85%
2005-12-31C$0.38 B10.7%
2004-12-31C$0.34 B-24.61%
2003-12-31C$0.46 B-13.34%
2002-12-31C$0.53 B-3%
2001-12-31C$0.55 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
C$108.04 B 2,524.37%๐Ÿ‡ฌ๐Ÿ‡ง UK
C$193.45 B 4,598.71%๐Ÿ‡ซ๐Ÿ‡ท France
C$156.64 B 3,704.71%๐Ÿ‡บ๐Ÿ‡ธ USA
C$130.27 B 3,064.23%๐Ÿ‡บ๐Ÿ‡ธ USA
C$126.40 B 2,970.08%๐Ÿ‡บ๐Ÿ‡ธ USA
C$247.96 B 5,922.64%๐Ÿ‡บ๐Ÿ‡ธ USA
C$300.68 B 7,203.13%๐Ÿ‡บ๐Ÿ‡ธ USA
C$70.11 M-98.30%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.14 B-96.58%๐Ÿ‡บ๐Ÿ‡ธ USA